Chondroitin sulfate - Bioiberica

Drug Profile

Chondroitin sulfate - Bioiberica

Alternative Names: Chondroitin sulfate CS b-Bioactive®; Chondroitin sulphate - Bioiberica; Condro-Sorb; Condrosan; Condrosulf (Bioiberica)

Latest Information Update: 30 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bioiberica
  • Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
  • Mechanism of Action Collagen stimulants; Leucocyte elastase inhibitors; Proteoglycan stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Musculoskeletal disorders; Osteoarthritis; Rheumatic disorders

Most Recent Events

  • 24 Apr 2018 Registered for Osteoarthritis (Combination therapy) in Finland, Poland, Hungary, Austria, France (PO) through mutual recognition process from Spain
  • 24 Apr 2018 Registered for Osteoarthritis (Combination therapy) in Spain (PO)
  • 24 Apr 2018 Bioiberica plans to launch the combination drug of chondroitin sulphate and glucosamine hydrochloride by 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top